146 related articles for article (PubMed ID: 15502424)
21. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
Hibino S; Uemura O; Nagai T; Yamakawa S; Iwata N; Ito H; Nakano M; Tanaka K
Pediatr Int; 2015; 57(1):85-91. PubMed ID: 25225083
[TBL] [Abstract][Full Text] [Related]
22. Guillain-Barré Syndrome secondary to tacrolimus in a patient with corticoresistant nephrotic syndrome caused by focal and segmental glomerulonephritis and IgA nephropathy.
Romaniouk Jakovler I; Perez Nieto C; Romero Antonio M; Simal Blanco F; Mouzo Javier R
Nefrologia (Engl Ed); 2018; 38(6):665-667. PubMed ID: 29246388
[No Abstract] [Full Text] [Related]
23. Evaluation and management of steroid-unresponsive nephrotic syndrome.
Del Rio M; Kaskel F
Curr Opin Pediatr; 2008 Apr; 20(2):151-6. PubMed ID: 18332710
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of methylprednisolone pulse therapy in steroid-resistant nephrotic syndrome.
Mori K; Honda M; Ikeda M
Pediatr Nephrol; 2004 Nov; 19(11):1232-6. PubMed ID: 15322892
[TBL] [Abstract][Full Text] [Related]
25. C1-C2 point monitoring of low-dose cyclosporin a given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome.
Nakahata T; Tanaka H; Tsugawa K; Kudo M; Suzuki K; Ito E; Waga S
Clin Nephrol; 2005 Oct; 64(4):258-63. PubMed ID: 16240896
[TBL] [Abstract][Full Text] [Related]
26. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.
Hamed RM
J Nephrol; 1997; 10(5):266-70. PubMed ID: 9364319
[TBL] [Abstract][Full Text] [Related]
27. Cyclophosphamide in the treatment of focal segmental glomerulosclerosis.
Martinelli R; Pereira LJ; Silva OM; Okumura AS; Rocha H
Braz J Med Biol Res; 2004 Sep; 37(9):1365-72. PubMed ID: 15334202
[TBL] [Abstract][Full Text] [Related]
28. Tacrolimus improves proteinuria remission in adults with cyclosporine A-resistant or -dependent minimal change disease.
Xu D; Gao X; Bian R; Mei C; Xu C
Nephrology (Carlton); 2017 Mar; 22(3):251-256. PubMed ID: 28035723
[TBL] [Abstract][Full Text] [Related]
29. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
30. Oral mizoribine pulse therapy for steroid-dependent focal segmental glomerulosclerosis.
Doi T; Masaki T; Shiraki N; Kawai T; Yorioka N
Clin Nephrol; 2008 Jun; 69(6):433-5. PubMed ID: 18538119
[TBL] [Abstract][Full Text] [Related]
31. [Cyclosporin A in the therapy of nephrotic syndrome caused by focal-segmental glomerulosclerosis].
Jovanović D; Kovacević Z; Rabrenović V
Vojnosanit Pregl; 2000; 57(3):303-7. PubMed ID: 11039311
[TBL] [Abstract][Full Text] [Related]
32. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
Gellermann J; Ehrich JH; Querfeld U
Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
[TBL] [Abstract][Full Text] [Related]
33. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children.
Gulati S; Prasad N; Sharma RK; Kumar A; Gupta A; Baburaj VP
Nephrol Dial Transplant; 2008 Mar; 23(3):910-3. PubMed ID: 18039644
[TBL] [Abstract][Full Text] [Related]
34. Treatment of childhood nephrotic syndrome.
Mendoza SA; Tune BM
J Am Soc Nephrol; 1992 Oct; 3(4):889-94. PubMed ID: 1450365
[TBL] [Abstract][Full Text] [Related]
35. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose.
Chishti AS; Sorof JM; Brewer ED; Kale AS
Am J Kidney Dis; 2001 Oct; 38(4):754-60. PubMed ID: 11576878
[TBL] [Abstract][Full Text] [Related]
36. Long-term Cyclosporine A (Sandimmun) therapy for steroid resistant nephrotic syndrome in children.
Sancewicz-Pach K; Słowiaczek E; Kwinta-Rybicka J; Wilkosz K; Drozdz D; Nowak J
Przegl Lek; 1996; 53(4):365-8. PubMed ID: 8711193
[TBL] [Abstract][Full Text] [Related]
37. Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis.
El-Reshaid K; El-Reshaid W; Madda J
Ren Fail; 2005; 27(5):523-30. PubMed ID: 16152989
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Efficacy of Tacrolimus Versus Cyclosporine in Childhood Steroid-Resistant Nephrotic Syndrome.
Shah SS; Hafeez F
J Coll Physicians Surg Pak; 2016 Jul; 26(7):589-93. PubMed ID: 27504551
[TBL] [Abstract][Full Text] [Related]
39. Effect of immunoadsorption on refractory idiopathic focal and segmental glomerulosclerosis.
Kuhn C; Kuhn A; Markau S; Kästner U; Osten B
J Clin Apher; 2006 Dec; 21(4):266-70. PubMed ID: 17120233
[TBL] [Abstract][Full Text] [Related]
40. Tacrolimus treatment in childhood refractory nephrotic syndrome: A retrospective study on efficacy, therapeutic drug monitoring, and contributing factors to variable blood tacrolimus levels.
Guo HL; Xu J; Sun JY; Li L; Guo HL; Jing X; Xu ZY; Hu YH; Xu ZJ; Sun F; Ding XS; Chen F; Zhao F
Int Immunopharmacol; 2020 Apr; 81():106290. PubMed ID: 32058933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
